Contraception
Volume 81, Issue 3 , Pages 223-225 , March 2010

Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects

  • Fernando Augusto Barreiros

      Affiliations

    • Department of Obstetrics and Gynecology, Sao Paulo Federal University Family Planning Clinic (UNIFESP), 1767 São Paulo, Brazil
    • Western Paulista University, Presidente Prudente, São Paulo, Brazil
    • ,
  • Cristina Aparecida Falbo Guazzelli

      Affiliations

    • Department of Obstetrics and Gynecology, Sao Paulo Federal University Family Planning Clinic (UNIFESP), 1767 São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 11 55722605; fax: +55 11 55722605.
    • ,
  • Ricardo Barbosa

      Affiliations

    • Western Paulista University, Presidente Prudente, São Paulo, Brazil
    • ,
  • Francisco de Assis

      Affiliations

    • Western Paulista University, Presidente Prudente, São Paulo, Brazil
    • ,
  • Fábio Fernando de Araújo

      Affiliations

    • Department of Obstetrics and Gynecology, Sao Paulo Federal University Family Planning Clinic (UNIFESP), 1767 São Paulo, Brazil

Received 25 August 2009 ,Revised 30 September 2009 ,Accepted 14 October 2009.

References 

  1. Plourd DM, Rayburn WF. New contraceptive methods. J Reprod Med. 2003;48:665–671
  2. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:64–72, 93.
  3. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol. 2002;186:1142–1149
  4. Miller L, Verhoeven CHJ, in't Hout J. Extended regimens of the contraceptive vaginal ring. Obstet Gynecol. 2005;3:473–482
  5. World Health Organization . In: Medical eligibility criteria for contraceptive use. 3rd ed.. Geneva: WHO; 2004;p. 112
  6. Altman D. In: Practical statistics for medical research. London: Chapman and Hall; 1991;p. 250
  7. Lewis MA, MacRae KD, Kuhl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO. The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod. 1999;14:1493–1499
  8. Fabian R. Hormonal contraception and its complications. Cesk Gynekol. 1987;52:210–212
  9. Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol. 2002;100:585–593
  10. Novák A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing®: an international study of user acceptability. Contraception. 2003;67:187–194
  11. Roumen F, Apter D, Mulders T, Dieben T. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod. 2001;16:469–475
  12. Roumen F. Review of the combined contraceptive vaginal ring, NuvaRing. Ther Clin Risk Manag. 2008;441–451

☆ There was no funding for this study.

PII: S0010-7824(09)00453-3

doi: 10.1016/j.contraception.2009.10.007

Contraception
Volume 81, Issue 3 , Pages 223-225 , March 2010

Article Tools

* Image Usage & Resolution